Results 171 to 180 of about 35,720 (287)

Tracking the Dynamics of human Colonisation and Adaptation in Central Vanuatu: Preliminary Results From Excavation and Survey at Pangpang, East Efate

open access: yesArchaeology in Oceania, EarlyView.
ABSTRACT In October 2022 an extensive archaeological landscape was identified by staff of the Vanuatu Cultural Centre at Pangpang on the east coast of Efate Island in central Vanuatu. It included midden deposits on the banks of the Pangpang River near the sea at Forari Bay where Lapita and Early Erueti‐style pottery sherds were recovered.
Stuart Bedford   +9 more
wiley   +1 more source

Armed gang violence in Haiti: a public mental health plan to navigate the horror and overcoming trauma. [PDF]

open access: yesLancet Reg Health Am
Cénat JM   +7 more
europepmc   +1 more source

Investigating the Heat Stability and Inactivation Conditions of Decapod Iridescent Virus 1 (DIV1)

open access: yesAnimal Research and One Health, EarlyView.
Heat treatment effectively inactivates decapod iridescent virus 1 (DIV1) under milder conditions than current WOAH recommendations. DIV1 infectivity was eliminated at 56°C for 30 min, 60°C for 15 min, or 70°C for 1 min, providing optimized heat treatment strategies for aquaculture biosecurity and seafood safety.
Yonghui Feng   +4 more
wiley   +1 more source

Rafid Keramane, La Pacification

open access: yesCahiers d’histoire, 2014
Didier Monciaud
doaj   +1 more source

A Geomorphometric Approach to Estimate the Deterioration of Earthen Archaeological Sites by Rainfall and Diffusion Processes: The Huaca Chornancap (Eighth–14th Century ad), Lambayeque, Peru

open access: yesArchaeological Prospection, EarlyView.
ABSTRACT Rain‐induced erosion processes can severely damage Earthen archaeological sites. Huaca Chornancap (HCH; eighth–14th century ad) is a platform located in the Lambayeque region (Peru) exposed to seasonal rain due to El Niño Southern Oscillation (ENSO).
Luigi Magnini   +5 more
wiley   +1 more source

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate to severe systemic lupus erythematosus (SLE) activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly
Susan Manzi   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy